61301-33-5
基本信息
五味子丙素对照品,
五味子丙素(标准品)
五味子丙素(五味子素C)
SCHISANDRIN C 五味子丙素
SCHISANDRIN C 五味子丙素 标准品
,8-dimethyl-
SCHIZANDRIN C
(S)-(-)-Schisandrin C
WUWEIZISU C USP/EP/BP
Schisandrin C >=98% (HPLC)
Schisandrin C (Schizandrin-C
Schisandrin C (S)-(-)-Schisandrin C
cycloocta(1,2-f:3,4-f’)bis(1,3)benzodioxole6,7,8,9-tetrahydro-1,13-dimethoxy-7
(6R,7S,13aS)-5,6,7,8-Tetrahydro-13,14-dimethoxy-6,7-dimethylcycloocta[1,2-f:3,4-f']bis[1,3]benzodioxole
物理化学性质
| 外观性状 | 无色晶体,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于五味子。 |
| 熔点 | 122-123℃ |
| 沸点 | 549.2±50.0 °C(Predicted) |
| 密度 | 1.232 |
| 储存条件 | 2-8°C |
| 溶解度 | DMSO : 8.33 mg/mL (21.67 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) |
| 形态 | 粉末 |
| 颜色 | 白色 |
| 主要应用 | metabolomics vitamins, nutraceuticals, and natural products |
| InChI | 1S/C22H24O6/c1-11-5-13-7-15-19(27-9-25-15)21(23-3)17(13)18-14(6-12(11)2)8-16-20(22(18)24-4)28-10-26-16/h7-8,11-12H,5-6,9-10H2,1-4H3 |
| InChIKey | HTBWBWWADZJXID-UHFFFAOYSA-N |
| SMILES | COC1=C2C(OCO2)=CC3=C1C(C(OC)=C(OCO4)C4=C5)=C5CC(C)C(C)C3 |
| LogP | 5.623 (est) |
安全数据
| 危险性符号(GHS) | ![]() ![]() GHS07,GHS09 |
| 警示词 | 警告 |
| 危险性描述 | H302-H410 |
| 防范说明 | P264-P270-P301+P312-P330-P501-P273-P391-P501 |
| WGK Germany | WGK 3 |
| 存储类别 | 11 - Combustible Solids |
应用领域
五味子丙素价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2026/09/15 | HY-N0690 | 五味子丙素 Schisandrin C | 61301-33-5 | 5 mg | 700元 |
| 2026/09/15 | HY-N0690 | 五味子丙素 Schisandrin C | 61301-33-5 | 10 mM * 1 mL in DMSO | 770元 |
| 2026/09/15 | HY-N0690 | 五味子丙素 Schisandrin C | 61301-33-5 | 10 mg | 980元 |
常见问题列表
Schisandrin C (25-100 μM; 48 hours) down-regulates expression levels of Bcl-2, Bcl-xL and a concomitant degradation of poly(ADP-ribose) polymerase (PARP). It also activates caspase-3 and -9 in U937 cells.Schisandrin C (25-100 μM; 48 hours) induces apoptosis in a dose-dependent manner. And the fragmentation of genomic DNA is also increased in U937 cells.Schisandrin C (25-100 μM; 72 hours) induces G1 arrest, it down-regulates cyclin D1, cyclin E, cyclin-dependent kinase (Cdk) 4 and E2Fs expression, and also exhibits inhibition of pRB, and up-regulation of the Cdk inhibitor p21(WAF1/CIP1).
Western Blot Analysis
| Cell Line: | U937 cells |
| Concentration: | 25 μM,50 μM,100 μM |
| Incubation Time: | 48 hours |
| Result: | Decreased the expression of apoptosis related proteins. |
Apoptosis Analysis
| Cell Line: | U937 cells |
| Concentration: | 25 μM,50 μM,100 μM |
| Incubation Time: | 48 hours |
| Result: | Induced cell apoptosis. |
Cell Cycle Analysis
| Cell Line: | U937 cells |
| Concentration: | 25 μM,50 μM,100 μM |
| Incubation Time: | 48 hours |
| Result: | Induced growth inhibition and G1 arrest of U937 cells. |
Schisandrin C (lateral ventricle injection (i.c.v.); 15-150 μg/kg; 5 days) reduces Aβ1-42-induced memory deficits in the Y-maze test. Neurons in the hippocampus of SCH-C (15 μg/kg)-treated group returned to normal level, and and SCH-C group (150 μg/kg) has slight neuroprotective effects Aβ1-42-induced group. SCH-C (15 μg/kg) recoveres the activities of SOD and GSHPx and the ratios of GSH, decreases the levels of ChEtotal in the brain of the Aβ1–42-induced amnesic mice simultaneously.
| Animal Model: | Aβ1-42-induced Alzheimer’s disease mice |
| Dosage: | 15-150 μg/kg |
| Administration: | Lateral ventricle injection (i.c.v.); 15-150 μg/kg; 5 days |
| Result: | Exhibited potent neuroprotective effects linking to anti-ChEtotal activities and anti-oxidative mechanisms in Aβ1-42-induced amnestic mice. |

